Lyme	B-KP	0,4
disease	I-KP	5,12
(	O	13,14
LD	B-KP	14,16
)	O	16,17
is	O	18,20
a	O	21,22
tick-borne	O	23,33
infection	O	34,43
caused	O	44,50
by	O	51,53
the	O	54,57
spirochete	B-KP	58,68
Borrelia	I-KP	69,77
burgdorferi	I-KP	78,89
.	O	89,90

Primary	O	91,98
LD	B-KP	99,101
commonly	O	102,110
presents	O	111,119
as	O	120,122
a	O	123,124
flu-like	O	125,133
ifiness	O	134,141
in	O	142,144
children	O	145,153
,	O	153,154
sometimes	O	155,164
accompanied	O	165,176
by	O	177,179
the	O	180,183
diagnostic	O	184,194
rash	O	195,199
known	O	200,205
as	O	206,208
erythema	B-KP	209,217
migrans	I-KP	218,225
(	O	226,227
EM	B-KP	227,229
)	O	229,230
.	O	230,231

[	O	232,233
1	O	233,234
]	O	234,235
Rheumatologic	B-KP	236,249
,	O	249,250
neurologic	B-KP	251,261
,	O	261,262
dermatologic	B-KP	263,275
,	O	275,276
or	O	277,279
cardiologic	B-KP	280,291
manifestations	O	292,306
in	O	307,309
systemic	O	310,318
LD	B-KP	319,321
may	O	322,325
follow	O	326,332
the	O	333,336
primary	O	337,344
infection	O	345,354
by	O	355,357
weeks	O	358,363
or	O	364,366
months	O	367,373
,	O	373,374
or	O	375,377
they	O	378,382
may	O	383,386
be	O	387,389
the	O	390,393
initial	O	394,401
presentation	O	402,414
of	O	415,417
LD	B-KP	418,420
.	O	420,421
A	O	422,423
wide	O	424,428
variety	O	429,436
of	O	437,439
neurologic	B-KP	440,450
syndromes	I-KP	451,460
have	O	461,465
been	O	466,470
reported	O	471,479
in	O	480,482
both	O	483,487
children	O	488,496
and	O	497,500
adults	O	501,507
with	O	508,512
LD	B-KP	513,515
,	O	515,516
ranging	O	517,524
from	O	525,529
acute	B-KP	530,535
myositis	I-KP	536,544
to	O	545,547
chronic	B-KP	548,555
encephalopathy	I-KP	556,570
.	O	570,571

However	O	572,579
,	O	579,580
facial	B-KP	581,587
palsy	I-KP	588,593
and	O	594,597
aseptic	B-KP	598,605
meningitis	I-KP	606,616
are	O	617,620
the	O	621,624
most	O	625,629
commonly	O	630,638
reported	O	639,647
neurologic	B-KP	648,658
manifestations	I-KP	659,673
.	O	673,674
[	O	675,676
2	O	676,677
]	O	677,678
The	O	679,682
nonspecificity	O	683,697
of	O	698,700
clinical	O	701,709
presentations	O	710,723
and	O	724,727
limitations	O	728,739
in	O	740,742
laboratory	O	743,753
diagnosis	O	754,763
complicate	O	764,774
the	O	775,778
diagnosis	O	779,788
of	O	789,791
neuroborreliosis	B-KP	792,808
.	O	808,809

While	O	810,815
Lyme	B-KP	816,820
serology	I-KP	821,829
is	O	830,832
considered	O	833,843
highly	O	844,850
sensitive	O	851,860
in	O	861,863
systemic	B-KP	864,872
LD	I-KP	873,875
,	O	875,876
false	O	877,882
positives	O	883,892
may	O	893,896
be	O	897,899
due	O	900,903
to	O	904,906
asymptomatic	B-KP	907,919
seroconversion	I-KP	920,934
,	O	934,935
antibodies	O	936,946
to	O	947,949
oral	B-KP	950,954
spirochetes	I-KP	955,966
,	O	966,967
prior	O	968,973
infection	O	974,983
,	O	983,984
or	O	985,987
immunologic	O	988,999
cross	O	1000,1005
reaction	O	1006,1014
to	O	1015,1017
other	O	1018,1023
pathogens	B-KP	1024,1033
.	O	1033,1034

Several	O	1035,1042
authors	O	1043,1050
have	O	1051,1055
emphasized	O	1056,1066
the	O	1067,1070
precedence	O	1071,1081
of	O	1082,1084
clinical	O	1085,1093
criteria	O	1094,1102
for	O	1103,1106
making	O	1107,1113
diagnostic	O	1114,1124
and	O	1125,1128
treatment	O	1129,1138
decisions	O	1139,1148
in	O	1149,1151
patients	O	1152,1160
with	O	1161,1165
suspected	O	1166,1175
LD	O	1176,1178
.	O	1178,1179
[	O	1180,1181
3-5	O	1181,1184
]	O	1184,1185
When	O	1186,1190
new	O	1191,1194
neurologic	O	1195,1205
symptoms	O	1206,1214
appear	O	1215,1221
in	O	1222,1224
concert	O	1225,1232
with	O	1233,1237
other	O	1238,1243
clinical	O	1244,1252
manifestations	O	1253,1267
typical	O	1268,1275
of	O	1276,1278
LD	B-KP	1279,1281
,	O	1281,1282
the	O	1283,1286
diagnosis	O	1287,1296
of	O	1297,1299
neuroborreliosis	B-KP	1300,1316
is	O	1317,1319
usually	O	1320,1327
secure	O	1328,1334
.	O	1334,1335

Because	O	1336,1343
individuals	O	1344,1355
with	O	1356,1360
systemic	O	1361,1369
signs	O	1370,1375
of	O	1376,1378
LD	B-KP	1379,1381
are	O	1382,1385
usually	O	1386,1393
seropositive	B-KP	1394,1406
,	O	1406,1407
we	O	1408,1410
reviewed	O	1411,1419
clinical	O	1420,1428
data	O	1429,1433
in	O	1434,1436
seropositive	B-KP	1437,1449
children	O	1450,1458
to	O	1459,1461
determine	O	1462,1471
1	O	1472,1473
)	O	1473,1474
how	O	1475,1478
often	O	1479,1484
the	O	1485,1488
initial	O	1489,1496
clinical	O	1497,1505
evaluation	O	1506,1516
permitted	O	1517,1526
a	O	1527,1528
diagnosis	O	1529,1538
of	O	1539,1541
neuroborreliosis	B-KP	1542,1558
,	O	1558,1559
and	O	1560,1563
2	O	1564,1565
)	O	1565,1566
the	O	1567,1570
range	O	1571,1576
of	O	1577,1579
neurologic	O	1580,1590
signs	O	1591,1596
in	O	1597,1599
children	O	1600,1608
with	O	1609,1613
positive	O	1614,1622
Lyme	B-KP	1623,1627
serology	I-KP	1628,1636
.	O	1636,1637

